Healthleap raises $38M to scale AI tool spotting at-risk hospital patients
Healthleap, a startup founded in South Africa in 2022, has raised $38 million across seed and Series A rounds to expand its AI platform that scans hospital patient records for signs of undiagnosed conditions. The funding includes an $8 million seed round co-led by Sequoia Capital and First Round Capital, plus a $30 million Series A led by Hummingbird Ventures. The company's system, now deployed in more than 50 hospitals, mines clinicians' written notes alongside structured data like labs and vitals to flag risks such as malnutrition and delirium.
GoKawiil's interpretation of the reporting above, not reported fact.
The sizable round suggests investors see strong demand for AI tools that extract insight from unstructured clinical notes, a data source many hospital systems underuse. Healthleap's pivot from a niche dietitian tool to a broader diagnostic-support platform indicates the company is betting on scaling its language-model approach across multiple conditions, though CEO Josiah Meyer notes several applications, like aspiration pneumonia and readmission risk, are still undergoing clinical validation. Wider adoption could hinge on how convincingly that validation holds up.
- Healthleap raised $38M total: $8M seed co-led by Sequoia and First Round, $30M Series A led by Hummingbird Ventures.
- The platform is already live in over 50 hospitals, screening for malnutrition and delirium using AI analysis of clinical notes.
- Additional disease-detection programs, including for pneumonia and heart failure readmission risk, are still being clinically validated.
Source: techcrunch.com — Ram Iyer, 2026-10-07
Published there as: “Healthleap raises $38M for its AI that flags hospital patients who may need a closer look”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.